The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV ...

Share on Pinterest The WHO has recommended the use of lenacapavir to help prevent HIV. Jakub Porzycki/NurPhoto via Getty Images The human immunodeficiency virus (HIV), which can lead to acquired ...

June 21 (UPI) --The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States plans to phase them out next year ...

Kenya will this year begin rollingout a new long-acting injectable HIV prevention drug, Lenacapavir, positioningthe country among the first in Africa to deploy the twice-yearly injection aspart of its ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization in the European Union (EU) for a twice-yearly injection ...

At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease unless they have received ART ...

Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...

New guidelines now allow HIV-positive mothers to breastfeed safely under strict medical protocols. The Trump administration ...